| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 236.79B | 234.97B | 228.81B | 221.98B | 218.61B | 234.15B |
| Gross Profit | 38.91B | 37.10B | 34.68B | 30.48B | 31.96B | 49.46B |
| EBITDA | 11.91B | 12.04B | -1.94B | 4.42B | 7.94B | 8.76B |
| Net Income | 4.80B | 5.49B | -9.41B | -4.99B | -376.00M | 412.00M |
Balance Sheet | ||||||
| Total Assets | 139.55B | 120.92B | 121.82B | 126.26B | 128.90B | 131.34B |
| Cash, Cash Equivalents and Short-Term Investments | 9.32B | 8.98B | 9.67B | 6.92B | 7.99B | 8.48B |
| Total Debt | 19.88B | 19.59B | 21.64B | 22.79B | 20.67B | 20.22B |
| Total Liabilities | 64.16B | 53.91B | 59.07B | 57.24B | 53.41B | 53.59B |
| Stockholders Equity | 74.54B | 66.20B | 62.01B | 68.33B | 74.83B | 77.14B |
Cash Flow | ||||||
| Free Cash Flow | 3.87B | -267.00M | 5.14B | -2.65B | 253.00M | 2.25B |
| Operating Cash Flow | 10.92B | 5.40B | 10.01B | 2.91B | 7.03B | 7.67B |
| Investing Cash Flow | -6.51B | -2.88B | -4.88B | -4.52B | -5.69B | -5.39B |
| Financing Cash Flow | -4.16B | -3.20B | -2.38B | 534.00M | -1.83B | -2.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥430.91B | 10.77 | 10.18% | 2.56% | 3.87% | 29.64% | |
72 Outperform | ¥501.16B | 15.17 | 9.86% | 2.58% | 1.08% | 2.71% | |
67 Neutral | ¥58.63B | 7.19 | 6.48% | 2.27% | 1.46% | ― | |
64 Neutral | ¥318.61B | 12.27 | ― | 2.61% | 6.54% | 15.08% | |
63 Neutral | ¥695.53B | 15.19 | 6.04% | 2.04% | 5.55% | 27.03% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
48 Neutral | ¥13.82B | 4.68 | ― | 1.61% | 0.48% | -34.95% |